CLASS II Device recall · Reported 28 Jul 2021 · FDA Enforcement Report

Citrasate Dry Acid Concentrate recalled by Fresenius Medical Care

Fresenius Medical Care Holdings is recalling Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be, distributed in Texas. The recall was initiated on 28 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number/UDI: (1) 21ATGF013 (01)00884086110135 0FD3251-3B (2) 20SXGF010 (01)00840861101597 0FD3251-3B (3) 20SXGF013 (01)00840861101597
Quantity recalled(1) 40 cases (2) 3 cases (3) 4 cases

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2084-2021
FDA event ID
87998
Recalling firm
Fresenius Medical Care Holdings, Waltham, MA
Classification
Class II
Status
Terminated
Recall initiated
28 Apr 2021
FDA classified
16 Jul 2021
Reported
28 Jul 2021
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Temperature Abuse

Timeline

28 Apr 2021Recall initiated by company
16 Jul 2021Classified by FDA+79 days
28 Jul 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Exposed to freezing temperatures due to refrigerated truck malfunctions

Foods that need refrigeration and were stored or shipped too warm can grow harmful bacteria without any change in look or smell.

Product as listed by the FDA

Citrasate Dry Acid Concentrate and GranuFlo Dry Acid Concentrate are each intended to be used as one component in the preparation of dialysate in a 3-stream proportioning hemodialysis machine according to a physician s prescription. Both concentrates are formulated for use in 45X proportioning systems which proportion a nominal ratio of 1 : 1.72 : 42.28 (acid : bicarbonate : water) to generate dialysate. The dialysate is intended to be pumped through a dialyzer, creating an osmotic gradient across the dialyzer membrane to exchange solutes with blood during hemodialysis.

Where it was distributed

US Distribution to: TX only

Texas

Questions about this recall

Why was it recalled?

Exposed to freezing temperatures due to refrigerated truck malfunctions

Which lots are affected?

Lot Number/UDI: (1) 21ATGF013 (01)00884086110135 0FD3251-3B (2) 20SXGF010 (01)00840861101597 0FD3251-3B (3) 20SXGF013 (01)00840861101597

Where was it sold?

US Distribution to: TX only

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

8 other products · FDA event 87998

This product is part of a recall event; the main page for the event is Citrasate Liquid Acid Concentrate recalled by Fresenius Medical Care.

More recalls from Fresenius Medical Care Holdings

All 165

Other Other Medical Devices recalls

All 13,778